Under the control of mutated epidermal growth factor receptor (EGFR), renin-angiotensin system (RAS), methionine (MET) or other tumorigenic pathways, vascular endothelial growth factor (VEGF) and other mediators are over-expressed in lung cancer patients. The gene discussed is EGFR; the disease is lung carcinoma.